Johnson & Johnson released numbers today from their phase 3 clinical trials (the last step before applying for emergency use authorization) and it looks like we may soon have a third viable COVID-19 vaccine in the US.
vendredi 29 janvier 2021
Lifehacker
What's Different About the Johnson & Johnson Vaccine?
Inscription à :
Publier les commentaires (Atom)
0 commentaires:
Enregistrer un commentaire